Interleukins, Signal Transduction, and the Immune System-Mediated Stress Response

  • R. L. Eskay
  • M. Grino
  • H. T. Chen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 274)


The interleukins (ILs) comprise a group of small proteins or polypeptides with molecular weights in the 15–25 kD range. These polypeptides possess pleiotropic biological activities on immune as well as non-immune cells and can be produced by either cell type. At the present time, recombinant forms for at least IL-lα and β through IL-7 are available for investigative use, and these ILs possess certain overlapping biological activities. The use of the term interleukin is somewhat archaic and limiting since a variety of non-leukocytic cell types produce these molecules or others with similar biological activities. Designations for the ILs, based on cell type of origin, include monokines, lymphokines, and cytokines if they are derived from monocytes, lymphocytes, and non-lymphoid cells, respectively. Finally, there is a trend to refer to all of the above mentioned molecules as cytokines, and an appreciation of the multitude of biological effects induced by the cytokines can be found in several recent reviews (1,2,3,4).


Newcastle Disease Virus Chromaffin Cell Pituitary Cell Vasoactive Intestinal Polypeptide POMC mRNA Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bendtzen, K., Interleukin 1, interleukin 6 and tumor neurosis factor in infaction, inflammation and immunity,Immun Lett19: 183–191, 1988.CrossRefGoogle Scholar
  2. 2.
    Dinarello, C.A., Interleukin-1 and its biologically related cytokines, In F.J. Dixon, (ed)Advances in ImmunologyAcademis Press, San Diego, Volume 44: 153–205, 1989.Google Scholar
  3. 3.
    Sipe, J.D., The molecular biology of interleukin-1 and the acute phase response, In G.H. Stollerman, W.J. Harrington, J.T. LaMont, J.J. Leonard, and M.D. Siperstein (eds)Advances in Internal Medicine,Year Book Medical Publishers, Inc. Chicago, Volume 34: 1–20, 1989.Google Scholar
  4. 4.
    Strober, W., and S.P. James, The interleukins,Pediatr Res24: 549–557, 1988.PubMedCrossRefGoogle Scholar
  5. 5.
    Blalock, J.E., A molecular basis for bidirectional communication between the immune and neuroendocrine systems,Physiol Rev69: 1–32, 1989.PubMedGoogle Scholar
  6. 6.
    Eskay, R.L., A. Thigarajan, and L. Eiden, Interleukin-1 enhances the accumulation of epinephrine and vasoactive-intestinal polypeptide in cultured adrenal chromaffin cells,Program of the I9th Annual Meeting of the Society for Neuroscience,Phoenix, AZ, Abstract 156.2, p. 380, 1989.Google Scholar
  7. 7.
    Besedovsky, H., E. Sorkin, D. Felix, and H. Haas, Hypothalamic changes during the immune response,Eur J Immunol7: 323–325, 1977.PubMedCrossRefGoogle Scholar
  8. 8.
    Besedovsky, H., E. Sorkin, M. Keller, and J. Müller, Changes in blood hormone levels during the immune response,Proc Soc Exp Biol Med150: 466–470, 1975.PubMedGoogle Scholar
  9. 9.
    Besedovsky, H.O., A. del Rey, and E. Sorkin, Lymphokine-containing supernatants from Con A-stimulated cells increase corticosterone blood levels, JImmunol126: 385–387, 1981.PubMedGoogle Scholar
  10. 10.
    Besedovsky, H.O., A. del Rey, E. Sorkin, and CA. Dinarello, Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones,Science233: 652–654, 1986.PubMedCrossRefGoogle Scholar
  11. 11.
    Besedovsky, H.O., A. del Rey, and E. Sorkin, Immun-neuroendocrine interactions, JImmunol135: 750s–754s, 1985.PubMedGoogle Scholar
  12. 12.
    Sapolsky, R., C. Rivier, G. Yamamoto, P. Plotsky, and W. Vale, Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor,Science238: 522–524, 1987.PubMedCrossRefGoogle Scholar
  13. 13.
    Berkenbosch, F., J. van Oers, A. del Rey, F. Tilders, and H. Besedovsky, Cortocotropin-releasing factor-producing neurons in the rat activated by interleukin-1,Science238: 524–526, 1987.PubMedCrossRefGoogle Scholar
  14. 14.
    Uehara, A., P.E. Gottschall, R.R. Dahl, and A. Arimura, Interleukin 1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor,Endocrinology121: 1580–1582, 1987.PubMedCrossRefGoogle Scholar
  15. 15.
    Katsuura, G., P.E. Gottschall, R.R. Dahl, and A. Arimura, Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin,Endocrinology122: 1773–1779,1988.PubMedCrossRefGoogle Scholar
  16. 16.
    Uehara, A., P.E. Gottschall, R.R. Dahl, and A. Arimura, Stimulation of ACTH release by human interleukin-1β, but not by interleukin-l, in conscious, freely-moving rats,Biochem Biophys Res Commun146: 1286–1290, 1987.PubMedCrossRefGoogle Scholar
  17. 17.
    Tsagarakis, S., G. Gillies, L.H. Rees, M. Besser, and A. Grossman, Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus,Neuroendocrinology49: 98–101, 1989.PubMedCrossRefGoogle Scholar
  18. 18.
    Ovadia, H., O. Abramsky, V. Barak, N. Conforti, D. Saphier, and J. Weidenfeld, Effect of interleukin-1 on adrenocortical activity in intact and hypothalamic deafferentated male rats,Exp Brain Res76: 246–249, 1989.PubMedCrossRefGoogle Scholar
  19. 19.
    Besedovsky, H., A. del Rey, E. Sorkin, M. da Prada, R. Burri, and C. Honegger, The immune response evokes changes in brain noradrenergic neurons,Science221: 564–566, 1983.PubMedCrossRefGoogle Scholar
  20. 20.
    Dunn, A J., M.L. Powell, W.V. Moreshead, J.M. Gaskin, and N.R. Hall, Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation,Brain Behav and Immunity1: 216–230, 1987.CrossRefGoogle Scholar
  21. 21.
    Dunn, A.J., Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone,Life Sci43: 429–435, 1988.PubMedCrossRefGoogle Scholar
  22. 22.
    Kabiersch, A., A. del Rey, C.G. Honegger, and H.O. Besedovsky, Interleukin-1 induces changes in norepinephrine metabolism in the rat brain,Brain Behav and Immunity2: 267–274,1988.CrossRefGoogle Scholar
  23. 23.
    Plotsky, P.M., Facilitation of immunoreactive corticotropin-releasing factor secretion into hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection,Endocrinology121: 924–930, 1987.PubMedCrossRefGoogle Scholar
  24. 24.
    Swanson, L.W., P.E. Sawchenko, and R.W. Lind, Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response, In T. Hökfelt, K. Fuxe, and B. Pernow (eds)Progress in Brain Research,Elsevier Science Publishers, New York, Volume 68: 169–190, 1986.Google Scholar
  25. 25.
    Szafarczyk, A., F. Malaval, A. Laurent, R. Gibaud, and I. Assenmacher, Further evidence for a central stimualtory action of catecholamines on adrenocorticotropin release in the rat,Endocrinology121:883–892, 1987.PubMedCrossRefGoogle Scholar
  26. 26.
    Farrar, W.L., J.M. Hill, A. Harel-Bellan, and M. Vinocour, The immune logical brain,Immunol Rev100: 361–378, 1987.PubMedCrossRefGoogle Scholar
  27. 27.
    Katsuura, G., P.E. Gottschall, and A. Arimura, Identification of a high-affinity receptor for interleukin-1 beta in the rat brain,Biochem Biophys Res Commun156: 61–67, 1988.PubMedCrossRefGoogle Scholar
  28. 28.
    Breder, C.D., C.A. Dinarella, and C.B. Saper, Interleukin-1 immunoreactive innervation of the human hypothalamus,Science240: 321–324, 1988.PubMedCrossRefGoogle Scholar
  29. 29.
    Nishida, T., N. Nishino, M. Takano, Y. Sekiguchi, K. Kawai, K. Mizuno, S. Nakai, Y. Masui, and Y. Hirai, Molecular cloning and expression of rat interleukin-1 alpha cDNA, JBiochem105: 351–357, 1989.PubMedGoogle Scholar
  30. 30.
    Nakamura, H., S. Motoyoshi, and T. Kadokawa, Anti-inflammatory action of interleukin 1 through the pituitary-adrenal axis in rats,Eur J Pharmacol151: 67–73, 1988.PubMedCrossRefGoogle Scholar
  31. 31.
    Sharp, B.M., S.G. Matta, P.K. Peterson, R. Newton, C. Chao, and K. McAllen, Tumor necrosis factor is a potent ACTH secretogogue: comparison to interleukin-1,Endocrinology124: 3131–3133, 1989.PubMedCrossRefGoogle Scholar
  32. 32.
    Kehrer, P., D. Turnill, J.M. Dayer, A.F. Muller, and R.C. Gaillard, Human recombinant interleukin-1 beta and -alpha, but not recombinant tumor necrosis factor alpha stimulate ACTH release from rat anterior pituitary cellsin vitroin a prostaglandin E2 and cAMP independent manner,Neuroendocrinology48: 160–166, 1988.PubMedCrossRefGoogle Scholar
  33. 33.
    Naitoh, Y., J. Fukata, T. Tominaga, Y. Nakai, S. Tamai, K. Mori, and H. Imura, Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats,Biochem Biophys Res Commun155: 1459–1463, 1988.PubMedCrossRefGoogle Scholar
  34. 34.
    Bindon, C., M. Czerniecki, P. Ruell, A. Edwards, W. McCarthy, R. Harris, and P. Hersey, Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects,Br J Cancer47: 123–133, 1983.PubMedCrossRefGoogle Scholar
  35. 35.
    Lotze, M.T., L.W. Frana, S.O. Sharrow, R.J. Robb, and S.A. Rosenberg,In vivoadministration of purified human interleukin 2. I. Half-like and immunologic effects of the Jurkat cell line-derived interleukin 2, JImmunol134: 157–166, 1985.PubMedGoogle Scholar
  36. 36.
    Lotze, M.T., Y.L. Matory, S.E. Ettinghausen, A.A. Rayner, S.O. Sharrow, C.A. Scipp; M.C. Custer, and S A. Rosenberg,In vivoadministration of purified human interleukin-2. II. Half-life, immunologic effects and expansion of peripheral lymphoid cellsin vivowith recombinant IL-2, JImmunol135: 2865–2875, 1985.PubMedGoogle Scholar
  37. 37.
    Michie, H.R., K.R. Manogue, D.R. Spriggs, A. Revhaug, S. O’Dwyer, CA. Dinarello, A. Cerami, S.M. Wolff, and D.W. Wilmore, Detection of circulating tumor necrosis factor after endotoxin administration,N Engl J Med318: 1481–1486, 1988.PubMedCrossRefGoogle Scholar
  38. 38.
    Smith, L.R., S.L. Brown, and J.E. Blalock, Interleukin-2 induction of ACTH secretion: pressure of an interleukin-2 receptor chain-like molecule on pituitary cells, JNeuroimmunol21: 249–254, 1989.PubMedCrossRefGoogle Scholar
  39. 39.
    Brown, S.L., L.R. Smith, and J.E. Blalock, Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells, JImmunol139: 3181–3183, 1987.PubMedGoogle Scholar
  40. 40.
    Farrar, W.L., Endorphin modulation of lymphokine activity, In F. Fraioli, A. Isidori, and M. Mazzetti (eds)Opioid Peptides in the Periphery, Elsevier, Amsterdam, pp. 159–165, 1984.Google Scholar
  41. 41.
    Bernton, E.W., J.E. Beach, J.W. Holaday, R.C. Smallridge, and H.G. Fein, Release of multiple hormones by direct action of interleukin-1 on pituitary cells,Science238: 519–521, 1987.PubMedCrossRefGoogle Scholar
  42. 42.
    Beach, J.E., R.C. Smallridge, C.A. Kinzer, E.W. Bernton, J.W. Holaday, and H.G. Fein, Rapid release of multiple hormones from rat pituitaries perfused with recombinant interleukin-1,Life Sci44:1–7,1989.PubMedCrossRefGoogle Scholar
  43. 43.
    Boyle, M., G. Yamamoto, M. Chen, J. Rivier, and W. Vale, Interleukin 1 prevents loss of corticotropic responsiveness to β-adrenergic stimulationin vitro, Proc Natl Acad Sci USA85: 5556–5560, 1988.PubMedCrossRefGoogle Scholar
  44. 44.
    Suda, T., F. Tozawa, T. Ushiyama, N. Tomori, T. Sumitomo, Y. Nakagami, M. Yamada, H. Demura, and K. Shizume, Effects of protein kinase-C-related adrenocorticotropin secretagogues and interleukin-1 on proopiomelanocortin gene expression in rat anterior pituitary cells,Endocrinology124: 1444–1449,1989.PubMedCrossRefGoogle Scholar
  45. 45.
    Uehara, A., S. Gillis, and A. Arimura, Effects of interleukin-1 on hormone release from normal rat pituitary cells in primary culture,Neuroendocrinology45: 343–347, 1987.PubMedCrossRefGoogle Scholar
  46. 46.
    Fagarasan, M.O., R. Eskay, and J. Axelrod, Interleukin 1 potentiates the secretion of β-endorphin induced by secretagogues in a mouse pituitary cell line (AtT-20),Proc Natl Acad Sci USA86: 2070–2073, 1989.PubMedCrossRefGoogle Scholar
  47. 47.
    Woloski, B.M., E.M. Smith, W.J. Meyer, G.M. Fuller, and J.E. Blalock, Corticotropin-releasing activity of monokines,Science230: 1035–1037, 1985.PubMedCrossRefGoogle Scholar
  48. 48.
    Axelrod, J., and T. Reisine, Stress hormones: their interaction and regulation,Science224: 452–459,1984.PubMedCrossRefGoogle Scholar
  49. 49.
    Young, S., P.J. Parker, A. Ullrich, and S. Stabel, Down-regulation of protein kinase-C is due to an increased rat of degradation,Biochem J244: 775–779, 1987,PubMedGoogle Scholar
  50. 50.
    Mitchell, P.J., and R. Tjian, Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins,Science245: 371–378, 1989.PubMedCrossRefGoogle Scholar
  51. 51.
    Malarkey, W.B., and B.J. Zvara, Interleukin-1ßand other cytokines stimulate adrenocorticotropin release from cultured pituitary cells of patients with Cushing’s disease, JClin Endocrinol Metab69:196–199,1989.PubMedCrossRefGoogle Scholar
  52. 52.
    Roh, M.S., M.O. Kathleen A. Drazenovich, J.J. Barbose, C.A. Dinarello, and C.F. Cobb, Direct stimulation of the adrenal cortex by interleukin-1,Surgery102: 140–146, 1987.PubMedGoogle Scholar
  53. 53.
    Whitcomb, R.W., W.M. Linehan, L.M. Wahl, and R.A. Knazek, Monocytes stimulate Cortisol production by cultured human adrenocortical cells, JClin Endocrinol Metab66: 33–38, 1988.PubMedCrossRefGoogle Scholar
  54. 54.
    Eiden, L.E., R.L. Eskay, J. Scott, H. Pollard, and A.J. Hotchkiss, Primary cultures of bovine chromaffin cells synthesize and secrete vasoactive intestinal polypeptide (VIP),Life Sci33: 687–693, 1983.PubMedCrossRefGoogle Scholar
  55. 55.
    Pruss, R.M., J.R. Moskal, L.E. Eiden, and M.C. Beinfeld, Specific regulation of vasoactive intestinal polypeptide biosynthesis by phorbal ester in bovine chromaffin cells,Endocrinology117:1020–1026,1985.PubMedCrossRefGoogle Scholar
  56. 56.
    Fong, Y., L. Moldawer, M. Marano, H. Wei, S.B. Tatter, R.H. Clarick, U. Santhanam, D. Sherris, L.T. May, P.B. Sehgal, and S.F. Lowry, Endotoxemia elicits increased circulating β2-IFN/IL-6 in man, JImmunol142: 2321–2324, 1989.PubMedGoogle Scholar
  57. 57.
    Zuckerman, S.H., J. Shellhaas, and L.D. Butler, Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis,Eur J Immunol19: 301–305, 1989.PubMedCrossRefGoogle Scholar
  58. 58.
    Stern,L., and G. Kunos, Synergistic regulation of pulmonary β-adrenergic receptors by glucocorticoids and interleukin-1,J Biol Chem263: 15876–15879,1988.PubMedGoogle Scholar
  59. 59.
    Vale, W., J. Vaughan, M. Smith, G. Yamamoto, J. Rivier, and C. Rivier, Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophyseal peptides and other substances on cultured corticotropin cells,Endocrinology113: 1121–1131, 1983.PubMedCrossRefGoogle Scholar
  60. 60.
    Dave, J.R. N. Rubenstein, and R.L. Eskay, Evidence that β-endorphin binds to specific receptors in rat peripheral tissues and stimulates the adenylate cyclase-adenosine 3′,5′-monophosphate system,Endocrinology117: 1389–1396, 1985.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • R. L. Eskay
    • 1
  • M. Grino
    • 1
  • H. T. Chen
    • 1
  1. 1.Laboratory of Clinical StudiesNational Institute on Alcohol Abuse and AlcoholismBethesdaUSA

Personalised recommendations